InMode (INMD) Net Margin (2018 - 2026)

InMode (INMD) posted Net Margin of 14.1% for Q1 2026, down 58.83% sequentially from 34.24% in Q4 2025, and down 928.0% YoY from 1.7% in Q1 2025.

InMode (INMD) Net Margin (2018 - 2026) Analysis & Trends

InMode has reported Net Margin for 9 years, with the latest figure at 14.1% in Q1 2026.

Quarterly Net Margin fell 928.0% year-over-year to 14.1% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25.55% (up 653.0% YoY) and the FY2025 annual result came in at 34.23%, up 747.0% from the prior year.
Net Margin slipped to 14.1% in Q1 2026 per INMD's latest filing, from 34.24% in the prior quarter.
Over five years, Net Margin peaked at 51.4% in Q4 2023 and troughed at 18.75% in Q4 2024.
A 5-year average of 30.41% and a median of 34.24% in 2025 frame the typical range for Net Margin.
The sharpest annual moves came in 2024 and 2025: Net Margin tumbled 7015 bps in 2024, then jumped 5299 bps in 2025.
Over 5 years, Net Margin stood at 28.23% in 2022, then soared by 82 bps to 51.4% in 2023, then slumped by 136 bps to 18.75% in 2024, then soared by 283 bps to 34.24% in 2025, then plunged by 59 bps to 14.1% in 2026.
According to Business Quant data, Net Margin over the past three periods registered 14.1%, 34.24%, and 23.47% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	7.37%
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	19.37%
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	12.84%
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	16.67%
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	13.87%
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	19.04%
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	10.84%
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	6.47%
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	13.47%
10	InMode	912.51 Mn	497.35 Mn	71.52 Mn	17.85%

Download Data